Projects
- Sixteen years of creatinine measurements among 460 000 individuals -The Funen Laboratory Cohort (FLaC), a population-based pharmaco-epidemiological resource to study drug-induced kidney disease
- Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome (PCOS)
- Hemolysis as a potential biomarker of occult disease
Available cohorts and infrastructures
The Funen Laboratory Cohort (FLaC)
Collaborators
- Daniel P. Henriksen, Department of Clinical Pharmacology, OUH
- Janne Cadamuro, Uniklinikum Salzburg, Austria
- The Nordic Preanalytical Scientific Working Group (under NFKK)
Selected publications
- Hansen RS, Revsholm J, Henriksen DP, Lund LC, Nybo M. Diagnoses and mortality in a population without acute myocardial infarction, but with elevated high-sensitive troponin I - a retrospective register-based single center study. Acute Med 2021;20:18-24
- Gils C, Sandberg MB, Nybo M. Verification of the hemolysis index measurement: imprecision, accuracy, measuring range, reference interval and impact of implementing analytically and clinically derived sample rejection criteria. Scand J Clin Lab Invest 2020;80:580-9
- Ersbøll AK, Kristensen MS, Nybo M, Møller Hede S, Mikkelsen KH, Gislason G, Lytken Larsen M, Green A. Trends in lo¬w-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study. PLoS One 2023;18:e0286376.
- Obel LM, Adelborg K, Pottegård A, Sørensen HT, Nybo M. Considerations for the Use of Biochemical Laboratory Registry Data in Clinical and Public Health Research. J Clin Epidemiol 2024;170:111337.
- Vermeersch P, de Jonge R, Miyazawa T, Nybo M, Fruekilde P, Toole B, et al. Comparison of six serum analyte workflows using routine liquid chromatography-tandem mass spectrometry methods at multiple laboratories with the Cobas i601 analyzer, an automated mass spectrometry system. Clin Chem Lab Med 2026: In press